Literature DB >> 20515613

Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis.

Hilla Solomon1, Ran Brosh, Yosef Buganim, Varda Rotter.   

Abstract

Since the discovery of the tumor suppressor p53 and the Ras oncogene, ample data have been accumulated, describing their aberrations in human cancer and their contribution to the multistep process of tumorigenesis. Several studies have also demonstrated that these dysregulated pathways cooperate to promote malignancy. Here we review recent studies on the cooperative molecular mechanisms by which p53 inactivation and oncogenic Ras converge to enhance tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515613

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  13 in total

1.  p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition.

Authors:  R Brosh; Y Assia-Alroy; A Molchadsky; C Bornstein; E Dekel; S Madar; Y Shetzer; N Rivlin; N Goldfinger; R Sarig; V Rotter
Journal:  Cell Death Differ       Date:  2012-09-21       Impact factor: 15.828

Review 2.  Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials.

Authors:  Girish B Maru; Rasika R Hudlikar; Gaurav Kumar; Khushboo Gandhi; Manoj B Mahimkar
Journal:  World J Biol Chem       Date:  2016-02-26

3.  Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.

Authors:  Noa Rivlin; Ran Brosh; Moshe Oren; Varda Rotter
Journal:  Genes Cancer       Date:  2011-04

4.  Stromal p53 Regulates Breast Cancer Development, the Immune Landscape, and Survival in an Oncogene-Specific Manner.

Authors:  Jinghai Wu; Xin Liu; Julie A Wallace Reeser; Anthony J Trimboli; Thierry Pécot; Gina M Sizemore; Shan K Naidu; Soledad A Fernandez; Lianbo Yu; Michael Hallett; Morag Park; Gustavo W Leone; Blake E Hildreth; Michael C Ostrowski
Journal:  Mol Cancer Res       Date:  2022-08-05       Impact factor: 6.333

5.  Association of GEMIN4 gene polymorphism and the risk of cancer: a meta-analysis.

Authors:  Nan Wu; Xiaowei Zhang; Jinlong Tian; Shuang Yu; Ying Qiao
Journal:  Onco Targets Ther       Date:  2017-11-02       Impact factor: 4.147

Review 6.  Molecular Pathways Controlling Autophagy in Pancreatic Cancer.

Authors:  Maria New; Tim Van Acker; Jaclyn S Long; Jun-Ichi Sakamaki; Kevin M Ryan; Sharon A Tooze
Journal:  Front Oncol       Date:  2017-03-03       Impact factor: 6.244

7.  Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer.

Authors:  Maher Albitar; Sucha Sudarsanam; Wanlong Ma; Shiping Jiang; Wayne Chen; Vincent Funari; Forrest Blocker; Sally Agersborg
Journal:  Oncotarget       Date:  2018-02-08

8.  Tumor-promoting circuits that regulate a cancer-related chemokine cluster: dominance of inflammatory mediators over oncogenic alterations.

Authors:  Tal Leibovich-Rivkin; Yosef Buganim; Hilla Solomon; Tsipi Meshel; Varda Rotter; Adit Ben-Baruch
Journal:  Cancers (Basel)       Date:  2012-01-20       Impact factor: 6.639

9.  The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells.

Authors:  Tal Leibovich-Rivkin; Yulia Liubomirski; Tsipi Meshel; Anastasia Abashidze; Daphna Brisker; Hilla Solomon; Varda Rotter; Miguel Weil; Adit Ben-Baruch
Journal:  BMC Cancer       Date:  2014-03-06       Impact factor: 4.430

Review 10.  Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer.

Authors:  Zhiqi Wang; Sai Li; Yu Cao; Xuefei Tian; Rong Zeng; Duan-Fang Liao; Deliang Cao
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.